Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): Applications for community-based HCV surveillance, education and prevention

<p>Abstract</p> <p>Background</p> <p>The hepatitis C virus (HCV) is a major cause of drug-related morbidity and mortality, with incidence data implicating a wide range of HCV transmission risk practices. The Blood-Borne Virus Transmission Risk Assessment Questionnaire (...

Full description

Saved in:
Bibliographic Details
Main Authors: Lintzeris Nicholas (Author), Fry Craig L (Author), Stoové Mark A (Author)
Format: Book
Published: BMC, 2008-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_beca5e4f093b4c7b8325fdaabb982b10
042 |a dc 
100 1 0 |a Lintzeris Nicholas  |e author 
700 1 0 |a Fry Craig L  |e author 
700 1 0 |a Stoové Mark A  |e author 
245 0 0 |a Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): Applications for community-based HCV surveillance, education and prevention 
260 |b BMC,   |c 2008-04-01T00:00:00Z. 
500 |a 10.1186/1477-7517-5-12 
500 |a 1477-7517 
520 |a <p>Abstract</p> <p>Background</p> <p>The hepatitis C virus (HCV) is a major cause of drug-related morbidity and mortality, with incidence data implicating a wide range of HCV transmission risk practices. The Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ) is a content valid instrument that comprehensively assesses HCV risk practices. This study examines the properties of a new weighted BBV-TRAQ designed to quantify HCV transmission risk among injecting drug users (IDU).</p> <p>Methods</p> <p>Analyses of cross-sectional surveys of Australian IDU (N = 450) were used to generate normative data and explore the properties of a weighted BBV-TRAQ. Items weights were assigned according to expert key informant ratings of HCV risk practices performed during the development stages of the BBV-TRAQ. A range of item weights was tested and psychometric properties explored. A weighting scheme was recommended based on the plausibility of normative subscale data in relation to research evidence and the ability of BBV-TRAQ scores to discriminate between HCV positive and negative participants.</p> <p>Results</p> <p>While retaining the psychometric properties of the unweighted scale and demonstrating good internal reliability. By taking into account the <it>relative </it>transmission risk of a broad range of putative HCV practices, the weighted BBV-TRAQ produced promising predictive validity results among IDU based on self-report HCV status, particularly among young and less experienced injectors.</p> <p>Conclusion</p> <p>Brief, easy to administer and score, and inexpensive to apply, the utility of the BBV-TRAQ for community based education and prevention is enhanced by the application of item weights, potentially offering a valid surrogate measure for HCV infection among IDU.</p> 
546 |a EN 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Harm Reduction Journal, Vol 5, Iss 1, p 12 (2008) 
787 0 |n http://www.harmreductionjournal.com/content/5/1/12 
787 0 |n https://doaj.org/toc/1477-7517 
856 4 1 |u https://doaj.org/article/beca5e4f093b4c7b8325fdaabb982b10  |z Connect to this object online.